Leah K Forsberg Selected Research

KU-596

1/2017

Modified biphenyl Hsp90 C-terminal inhibitors for the treatment of cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leah K Forsberg Research Topics

Disease

4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2017
4	Neoplasms (Cancer) 01/2018 - 09/2014
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 01/2020
2	Dementia (Dementias) 01/2021 - 10/2020
1	Frontotemporal Dementia (Semantic Dementia) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

4	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2014
1	GranulinsIBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2020
1	Novobiocin (Streptonivicin)FDA Link 11/2017
1	benzamideIBA 01/2017
1	acetamideIBA 01/2017
1	diphenyl (biphenyl)IBA 01/2017
1	KU-596IBA 01/2017
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2017

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020